<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566888</url>
  </required_header>
  <id_info>
    <org_study_id>HS-17-00139</org_study_id>
    <nct_id>NCT03566888</nct_id>
  </id_info>
  <brief_title>Validation of a Noninvasive Automated Blood Pressure Device</brief_title>
  <official_title>Validation of a Noninvasive Automated Blood Pressure Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator's objective is to validate the novel automated blood pressure device against
      the requirements set forth in the AAMI_ISO 81060-2:2010 standard in voluntarily consented
      study participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A new prototype blood pressure cuff has been designed for the higi SH llc health stations.
      This new cuff accurately captures blood pressure (BP) by emulating a fitted cuff which is
      used in conjunction with a mercury sphygmomanometer, the accepted gold standard for measuring
      BP values in most clinical facilities. The cuff is driven by a motor and gearhead to
      automatically &quot;wrap&quot; the cuff around a user's arm when they initiate a BP test. A BP
      measurement is then taken by an Original Equipment Manufacturer (OEM) BP module using an
      algorithm developed for use with a fitted cuff; the same module one would expect to find in a
      clinic or doctor's office. For the device to pass the AAMI_ISO 81060-2:2010 standard
      statistical requirements and thus, be considered a valid device for measuring BP it will need
      to meet the standards criteria 1 and 2.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">October 2, 2018</completion_date>
  <primary_completion_date type="Actual">October 2, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic and Diastolic blood pressure (criteria 1 and 2)</measure>
    <time_frame>60 minutes</time_frame>
    <description>Mean value of the differences of the paired (i.e., device under test - reference method) determinations for all study participants shall be within or equal to Â± 5 mmHg with a standard deviation no greater than 8 mmHg (criterion 1). Standard deviation of the averaged paired determinations per participant shall meet the criterion 2 listed in the standard.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">85</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Single Group</arm_group_label>
    <description>85 eligible study participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Blood pressure assessment</intervention_name>
    <description>Validation of an automated blood pressure device</description>
    <arm_group_label>Single Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals between the ages of 12-92 years, generally healthy, and have not been diagnosed
        with heart disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  between the ages of 12 to 92 years of age.

          -  generally healthy but can be on medication for blood pressure regulation.

        Exclusion Criteria:

          -  heart disease is present such as, coronary artery disease, cardiomegaly, irregular
             heart rhythm, atrial fibrillation, heart valve disease, congenital heart disease,
             cardiomyopathy, pericardial effusion, Marfan syndrome, and heart murmurs.

          -  using a pacemaker to maintain a suitable heart rate.

          -  missing their natural left arm.

          -  exhibit a musculoskeletal disorder that may prevent them from sitting upright for a
             period of time (~40min) or prevent a BP reading taken from the left arm.

          -  Special populations, for example pregnant women and patients with known arrhythmias.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>92 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd Schroeder, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>June 12, 2018</study_first_submitted>
  <study_first_submitted_qc>June 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <last_update_submitted>November 6, 2018</last_update_submitted>
  <last_update_submitted_qc>November 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Todd Schroeder</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

